Correlation Between Edgewise Therapeutics and Carmell Therapeutics
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Carmell Therapeutics, you can compare the effects of market volatilities on Edgewise Therapeutics and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Carmell Therapeutics.
Diversification Opportunities for Edgewise Therapeutics and Carmell Therapeutics
-0.82 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Edgewise and Carmell is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Carmell Therapeutics go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Carmell Therapeutics
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.33 times more return on investment than Carmell Therapeutics. However, Edgewise Therapeutics is 3.05 times less risky than Carmell Therapeutics. It trades about 0.13 of its potential returns per unit of risk. Carmell Therapeutics is currently generating about 0.02 per unit of risk. If you would invest 687.00 in Edgewise Therapeutics on September 2, 2024 and sell it today you would earn a total of 2,613 from holding Edgewise Therapeutics or generate 380.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 31.45% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Carmell Therapeutics
Performance |
| Timeline |
| Edgewise Therapeutics |
| Carmell Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Insignificant
Edgewise Therapeutics and Carmell Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Carmell Therapeutics
The main advantage of trading using opposite Edgewise Therapeutics and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.| Edgewise Therapeutics vs. Tff Pharmaceuticals | Edgewise Therapeutics vs. Eliem Therapeutics | Edgewise Therapeutics vs. Inhibrx | Edgewise Therapeutics vs. Enliven Therapeutics |
| Carmell Therapeutics vs. Sonida Senior Living | Carmell Therapeutics vs. Akanda Corp | Carmell Therapeutics vs. IPG Photonics | Carmell Therapeutics vs. NextNav Warrant |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |